Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
MEDP Medpace Holdings Inc
- Stocks
- Healthcare
- NASDAQ: MEDP
Price (delayed)
$312.74
Market cap
$8.99B
P/E Ratio
23.15
Dividend/share
N/A
EPS
$13.51
Enterprise value
$8.67B
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate
Highlights
The net income has increased by 33% YoY and by 3% from the previous quarter
The EPS is up by 33% YoY and by 3.4% QoQ
Medpace Holdings's equity has decreased by 28% from the previous quarter and by 12% YoY
Medpace Holdings's quick ratio has decreased by 24% QoQ and by 8% YoY
Key stats
What are the main financial stats of MEDP
Market
Valuations
Earnings
Shares outstanding
28.74M
Market cap
$8.99B
Enterprise value
$8.67B
Price to earnings (P/E)
23.15
Price to book (P/B)
16.05
Price to sales (P/S)
4.41
EV/EBIT
18.84
EV/EBITDA
16.9
EV/Sales
4.02
Revenue
$2.16B
Gross profit
$679.51M
Operating income
$456.32M
Net income
$416.39M
EBIT
$460.43M
EBITDA
$513.12M
Free cash flow
$540.93M
Per share
Balance sheet
Liquidity
EPS
$13.51
EPS diluted
$13.1
Free cash flow per share
$17.8
Book value per share
$19.48
Revenue per share
$70.97
TBVPS
$39.52
Total assets
$1.9B
Total liabilities
$1.3B
Debt
$126.66M
Equity
$593.61M
Working capital
-$300.87M
Debt to equity
0.21
Current ratio
0.73
Quick ratio
0.66
Net debt/EBITDA
-0.61
Margins
Efficiency
Dividend
EBITDA margin
23.8%
Gross margin
31.5%
Net margin
19.3%
Operating margin
21.2%
Return on assets
20.8%
Return on equity
54.4%
Return on invested capital
N/A
Return on capital employed
59.4%
Return on sales
21.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MEDP stock price
How has the Medpace Holdings stock price performed over time
Intraday
2.18%
1 week
6.44%
1 month
2.5%
1 year
-20.56%
YTD
-5.87%
QTD
2.64%
Financial performance
How have Medpace Holdings's revenue and profit performed over time
Revenue
$2.16B
Gross profit
$679.51M
Operating income
$456.32M
Net income
$416.39M
Gross margin
31.5%
Net margin
19.3%
The net income has increased by 33% YoY and by 3% from the previous quarter
The operating income has increased by 29% year-on-year and by 2.1% since the previous quarter
MEDP's gross profit is up by 24% year-on-year and by 3.5% since the previous quarter
The net margin is up by 21% year-on-year
Price vs fundamentals
How does MEDP's price correlate with its fundamentals
Growth
What is Medpace Holdings's growth rate over time
Valuation
What is Medpace Holdings stock price valuation
P/E
23.15
P/B
16.05
P/S
4.41
EV/EBIT
18.84
EV/EBITDA
16.9
EV/Sales
4.02
The EPS is up by 33% YoY and by 3.4% QoQ
The P/E is 25% lower than the 5-year quarterly average of 31.0 and 18% lower than the last 4 quarters average of 28.4
MEDP's price to book (P/B) is 29% higher than its 5-year quarterly average of 12.4 and 13% higher than its last 4 quarters average of 14.2
Medpace Holdings's equity has decreased by 28% from the previous quarter and by 12% YoY
MEDP's price to sales (P/S) is 14% less than its last 4 quarters average of 5.1 and 12% less than its 5-year quarterly average of 5.0
MEDP's revenue is up by 10% year-on-year and by 2.3% since the previous quarter
Efficiency
How efficient is Medpace Holdings business performance
The ROS is up by 16% YoY
The company's return on equity fell by 9% YoY but it rose by 6% QoQ
Medpace Holdings's return on assets has increased by 6% YoY
Dividends
What is MEDP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MEDP.
Financial health
How did Medpace Holdings financials performed over time
The company's total assets is 46% higher than its total liabilities
Medpace Holdings's quick ratio has decreased by 24% QoQ and by 8% YoY
Medpace Holdings's current ratio has decreased by 22% QoQ and by 6% YoY
The debt is 79% smaller than the equity
MEDP's debt to equity is up by 40% since the previous quarter and by 5% year-on-year
Medpace Holdings's equity has decreased by 28% from the previous quarter and by 12% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.